USPTO-FDA Joint Engagements

On July 9, 2021, President Biden signed Executive Order (EO) 14036 on “Promoting Competition in the American Economy." In response, the U.S. Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO) have agreed to collaborate to ensure that our system supports meaningful innovation in drug development and a competitive marketplace with greater access to medicines for American families. 

To encourage feedback about these collaboration initiatives, the USPTO and the FDA are hosting joint events in which the public can learn about existing proposals, ask questions, and comment on areas for collaboration and engagement between the agencies.

You can find upcoming and past USPTO-FDA engagement events on this page. You can also view their agendas and listen to recordings of previous events by selecting them.